A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.

Scientists leading the trial at University College London believe the blood test could improve the accuracy of diagnosis of the disease to more than 90%.

Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the diagnosis of Alzheimer's disease.

The accessible technology, say researchers, opens the door to wider screening and more prompt intervention for Alzheimer's ...

A leading neuropsychologist says President Donald Trump should undergo modern Alzheimer’s screening after a string of “odd ...

Researchers say the experimental tool has huge implications for public health, especially in conjunction with Alzheimer’s ...

Alzheimer's disease is a heartbreaking and complicated condition, slowly taking away memory, thinking, and independence.

A new passive brainwave test records brain activity while patients view images to detect memory-related changes linked to ...

A revolutionary blood test, set to transform how Alzheimer's disease is diagnosed, could save the NHS time and money. A clinical trial for the blood test is now welcoming its first participants, who ...

A three-minute brainwave scan called Fastball EEG can uncover memory decline linked to Alzheimer’s years early, offering a ...

Dr Narinder Kapur, a consultant neuropsychologist and visiting professor of neuropsychology at University College London, ...